On Demand Learning

24 Results

  • Q&A Session: Treatment of Perinatal Opioid Use Disorder via Telemedicine

    Contains 3 Component(s) Recorded On: 11/11/2020

    This is the sixth Q & A webinar in the telehealth series for the Opioid Response Network (ORN). Post your questions at: https://docs.google.com/document/d/1jWnx8vzasVmq_zIV9nLWIRr4qYJ14oiYHYr7w2HTd1w/edit?usp=sharing Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Treatment of Perinatal Opioid Use Disorder via Telemedicine

    Contains 3 Component(s) Recorded On: 11/04/2020

    This is the sixth webinar in the telehealth series for the Opioid Response Network (ORN). The webinar will describe the use of telemedicine to create integrated mental health and substance use disorder treatment services for pregnant and postpartum women receiving prenatal care in an obstetric setting. The webinar will describe outcomes for pregnant women with Opioid Use Disorder and how technology is being leveraged during COVID-19 to improve detection and treatment of maternal mental health and substance use disorders. Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Q&A Session: The Current Evidence On Telemedicine-Delivered Treatment for Opioid and Other Substance Use Disorders

    Contains 3 Component(s) Recorded On: 10/21/2020

    This is the fifth Q & A webinar in the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

  • The Current Evidence On Telemedicine-Delivered Treatment for Opioid and Other Substance Use Disorders

    Contains 3 Component(s) Recorded On: 10/14/2020

    This is the fifth webinar in the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

  • Q&A - Telemedicine for OUD in the Indian Health Service

    Contains 3 Component(s) Recorded On: 08/26/2020

    This webinar is part of the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

  • Telemedicine for OUD in the Indian Health Service

    Contains 3 Component(s) Recorded On: 08/19/2020

    This is the fourth webinar in the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.